Author:
Alfano Massimo,Canducci Filippo,Nebuloni Manuela,Clementi Massimo,Montorsi Francesco,Salonia Andrea
Publisher
Springer Science and Business Media LLC
Reference243 articles.
1. Parkin, D. M., Bray, F., Ferlay, J. & Pisani, P. Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74–108 (2005).
2. Babjuk, M. et al. Guidelines on non-muscle-invasive (TA, T1, CIS) bladder cancer. Eur. Urol. 59, 584–594 (2013).
3. Witjes, J. A. et al. Guidelines on muscle-invasive and metastatic bladder cancer. European Association of Urology
[online]
, (2015).
4. Zargar, H., Aning, J., Ischia, J., So, A. & Black, P. Optimizing intravesical mitomycin C therapy in non-muscle-invasive bladder cancer. Nat. Rev. Urol. 11, 220–230 (2014).
5. Redelman-Sidi, G., Glickman, M. S. & Bochner, B. H. The mechanism of action of BCG therapy for bladder cancer—a current perspective. Nat. Rev. Urol. 11, 153–162 (2014).
Cited by
90 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献